Summary
CME Group Inc. (CME) has filed an 8-K report detailing the completion of a significant public offering of debt securities. The company successfully issued $500 million in 3.750% Notes due 2028 and $700 million in 4.150% Notes due 2048, totaling $1.2 billion. These proceeds are earmarked to finance the cash consideration for its previously announced acquisition of NEX Group plc, which is still anticipated to close in the latter half of 2018. This debt issuance diversifies CME's funding sources and provides the necessary capital for a major strategic acquisition. Investors should note the specific terms of the notes, including interest rates, maturity dates, and redemption provisions. A key contingency mentioned is that if the NEX Group acquisition does not close by June 30, 2019, or is terminated, CME will be required to redeem all outstanding notes at a premium, indicating a direct financial link between the acquisition's success and the debt obligations.
Key Highlights
- 1Completed a $1.2 billion public offering of notes: $500 million in 3.750% Notes due 2028 and $700 million in 4.150% Notes due 2048.
- 2Proceeds will be used to finance the cash component of the previously announced acquisition of NEX Group plc.
- 3The acquisition of NEX Group plc is expected to close in the second half of 2018.
- 4The notes are governed by an Indenture, with covenants that may limit the company's ability to incur liens, engage in sale and leaseback transactions, and undergo mergers or asset sales.
- 5In case of a change of control, CME will be required to offer to repurchase the notes at 101% of the principal amount.
- 6If the NEX Group acquisition is not consummated by June 30, 2019, or is terminated, CME must redeem all outstanding notes at 101% of the principal amount.